Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐ NHL ‐2010M

Author:

Maschan Alexey1ORCID,Myakova Natalia1,Aleinikova Olga2,Abugova Yulia1,Ponomareva Natalia3,Belogurova Margarita4,Fechina Larisa5,Fedorova Alina2,Grigor'eva Natalia6,Lebedev Vladimir7,Nikonova Olga8,Shamardina Anastassia9,Sharapova Guzel10,Smirnova Nadezhda1,Rudneva Anastassia1,Volchkov Egor1,Samochatova Elena1

Affiliation:

1. Dmitri Rogachev National Research Centre for Paediatric Haematology, Oncology and Immunology Moscow Russian Federation

2. Belorussian Research Centre for Paediatric Oncology, Haematology and Immunology Minsk Russian Federation

3. Russian Children's Hospital MoscowRussian Federation

4. City Clinical Hospital No. 31 St. Petersburg Russian Federation

5. Regional Children's Clinical Hospital No. 1 Ekaterinburg Russian Federation

6. Regional Children's Clinical Hospital Arkhangelsk Russian Federation

7. Regional Children's Clinical Hospital KrasnodarRussian Federation

8. Regional Children's Clinical Hospital Perm Russian Federation

9. Regional Children's Clinical Hospital Nizhny Novgorod Russian Federation

10. District Clinical Children's Hospital Nizhnevartovsk Russian Federation

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3